by Plexium IT Department | Sep 29, 2022 | All Posts, Press Releases
San Diego, California, September 29, 2022 – Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of Suzanne Zoumaras as Executive Vice President, Head of Human Resources. Ms. Zoumaras is an...
by Amy Conrad | Aug 24, 2022 | All Posts
San Diego, California, [August 24, 2022] – Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of Daniel Sipes as Senior Vice President, Head of Technology. Mr. Sipes brings over two decades of...
by Plexium IT Department | Nov 4, 2021 | All Posts, Press Releases
San Diego, Calif., November 4, 2021 – Plexium Inc., (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of experienced biopharmaceutical leader Percival Barretto-Ko as President and Chief Executive Officer...
by Plexium IT Department | Oct 7, 2021 | All Posts, Press Releases
SAN DIEGO, Oct. 5, 2021 – Plexium Inc., (Plexium), a biotech company focused on discovering and developing protein degrading therapeutics directed towards historically challenging drug targets, today announced that company management will present and host one-on-one...
by Plexium IT Department | Jan 21, 2021 | All Posts, Press Releases
Company also announces appointment of biotech veteran Mike Grey as Chairman of the Board SAN DIEGO, October 19, 2020 – Plexium Inc., a biotech company focused on discovering and developing protein degrading therapeutics directed towards historically challenging drug...
by Plexium IT Department | Oct 17, 2019 | All Posts, Press Releases
Funds will help advance Plexium’s DELPhe platform to discover novel E3 ligase-modulating therapeutics to treat cancer and neurodegenerative diseases SAN DIEGO, October 17, 2019 – Plexium today announced the launch of the company with the closing of a $28 million...
